<DOC>
	<DOCNO>NCT02805426</DOCNO>
	<brief_summary>This study randomize , double-blind , placebo control trial enroll 250 woman ( 125 per study arm ) . The objective study determine efficacy tolerability oral tranexamic acid use adjunct misoprostol treatment postpartum hemorrhage ( PPH ) . Women diagnose postpartum hemorrhage blood loss reach 700ml calibrated receptacle . If diagnose postpartum hemorrhage , woman randomize receive either tranexamic acid placebo , tablet form . All participant receive 800 mcg sublingual misoprostol ( 4 tablet 200mcg ) . The investigator hypothesize tranexamic acid ( tablet form ) adjunct misoprostol effective misoprostol alone stop postpartum bleed without recourse treatment significantly woman .</brief_summary>
	<brief_title>Effectiveness Tranexamic Acid When Used Adjunct Misoprostol Treatment Postpartum Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Women delivery vaginally Women experience PPH define blood loss â‰¥700ml Women capable give consent Clear contraindication tranexamic acid know allergy thromboembolic event pregnancy Women deliver via cesarean section Provider feel woman , presentation delivery , position give appropriate inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>